Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.
A reporter’s PressPass is required to access this story until the embargo expires on 11-Jun-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.
Study Examines COVID-19 Among Patients Receiving Home Dialysis
• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.
Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis
• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination. • Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.
New treatment demonstrated for people with vaccine clots
The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.
The Medical Minute: Vaccinating kids against COVID-19 protects them, their communities
Is the Pfizer BioNTech vaccine really safe for children ages 12 and up? A Penn State Health expert gives an emphatic yes.
Normal Breathing Sends Saliva Droplets 7 Feet; Masks Shorten This
The WHO and the CDC recommend keeping a certain distance between people to prevent the spread of COVID-19. These social distancing recommendations are estimated from a variety of studies, but further research about the precise mechanism of virus transport is still needed. In Physics of Fluids, researchers demonstrate normal breathing indoors without a mask can transport saliva droplets capable of carrying virus particles to a distance of 2.2 meters in a matter of 90 seconds.
SARS-CoV-2 Detectable — Though Likely Not Transmissible — on Hospital Surfaces
UC San Diego School of Medicine researchers discovered that SARS-CoV-2, or at least its genetic signature, abounds on hospital surfaces, often co-locating with one particular type of bacteria.
Live Virtual Event for June 17: New JAMA study answers whether COVID-19 vaccines can impact male fertility
This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.